Assessment of type I interferon response in routine practice in France in 2022.

An European Alliance of Associations for Rheumatology task force recently recommended specific points to consider for exploring type I interferon pathway in patients, highlighting the lack of analytical assays validated for clinical routine. We report here the French experience on a type I interferon pathway assay that has been set up and used routinely since 2018 in Lyon, France. © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Citation

Anais Nombel, Anne Perrine Foray, Lorna Garnier, Christine Lombard, Eric Hachulla, Brigitte Bader-Meunier, Sophie Georgin-Lavialle, Isabelle Melki, Thierry Walzer, Alexandre Belot, Sebastien Viel. Assessment of type I interferon response in routine practice in France in 2022. RMD open. 2023 Jun;9(2)

Mesh Tags

Substances

PMID: 37321666

search → result